Correlation Between Immutep and GeneThera
Can any of the company-specific risk be diversified away by investing in both Immutep and GeneThera at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immutep and GeneThera into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immutep Ltd ADR and GeneThera, you can compare the effects of market volatilities on Immutep and GeneThera and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immutep with a short position of GeneThera. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immutep and GeneThera.
Diversification Opportunities for Immutep and GeneThera
Pay attention - limited upside
The 3 months correlation between Immutep and GeneThera is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Immutep Ltd ADR and GeneThera in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneThera and Immutep is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immutep Ltd ADR are associated (or correlated) with GeneThera. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneThera has no effect on the direction of Immutep i.e., Immutep and GeneThera go up and down completely randomly.
Pair Corralation between Immutep and GeneThera
If you would invest 192.00 in Immutep Ltd ADR on August 28, 2024 and sell it today you would earn a total of 10.00 from holding Immutep Ltd ADR or generate 5.21% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Immutep Ltd ADR vs. GeneThera
Performance |
Timeline |
Immutep Ltd ADR |
GeneThera |
Immutep and GeneThera Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Immutep and GeneThera
The main advantage of trading using opposite Immutep and GeneThera positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immutep position performs unexpectedly, GeneThera can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneThera will offset losses from the drop in GeneThera's long position.Immutep vs. Ocean Biomedical | Immutep vs. Elevation Oncology | Immutep vs. Zura Bio Limited | Immutep vs. Cns Pharmaceuticals |
GeneThera vs. Rigel Pharmaceuticals | GeneThera vs. Geron | GeneThera vs. Verastem | GeneThera vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Bonds Directory Find actively traded corporate debentures issued by US companies |